8r-70car
Cell therapyexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2022 (NCT05353530)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- CD70 antigenBINDING AGENT
CD70
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06946680 | Phase 1 | Mar 18, 2025 | American Brain Tumor Association, St. Baldrick's Foundation, University of Florida |
| NCT05353530 | Phase 1 | Oct 31, 2022 | AM Rosen Foundation, Department of Defense, University of Florida |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Florida | Academic/Hospital | 2 | 2 | 1 | 2022 |
| American Brain Tumor Association | Academic/Hospital | 1 | 0 | 1 | 2025 |
| AM Rosen Foundation | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Department of Defense | Government | 1 | 0 | 1 | 2022 |
| St. Baldrick's Foundation | Academic/Hospital | 1 | 0 | 1 | 2025 |
5 organizations
Page 1 / 1